...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis
【24h】

Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis

机译:培美曲塞双重治疗与单独培美曲塞作为晚期非小细胞肺癌二线治疗的有效性和安全性:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

To compared pemetrexed-based doublet with single-agent pemetrexed as second-line treatment for advanced non-small-cell lung cancer
机译:比较以培美曲塞为基础的双重治疗与培美曲塞单药作为晚期非小细胞肺癌的二线治疗

著录项

  • 来源
    《Journal of Cancer Research and Clinical Oncology》 |2012年第5期|p.745-751|共7页
  • 作者单位

    Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China;

    Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China;

    Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China;

    Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China;

    Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Non-small-cell lung cancer; Second-line therapy; Pemetrexed; Meta-analysis;

    机译:非小细胞肺癌;二线治疗;培美曲塞;Meta分析;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号